Day: November 6, 2025

Dallas, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported a net loss attributable to NL stockholders of $7.8 million, or $.16 per share, in the third quarter of 2025 compared to net income attributable to NL stockholders of $36.0 million, or $.74 per share, in the third quarter of 2024. NL results include an unrealized loss of $.5 million in the third quarter of 2025 related to the change in value of marketable equity securities compared to an unrealized gain of $18.6 million in the third quarter of 2024. For the first nine months of 2025, NL reported a net loss attributable to NL stockholders of $6.8 million, or $.14 per share, compared to net income attributable to NL stockholders of $50.7 million, or $1.04 per share, for the first nine months of 2024. NL results include an unrealized loss...

Steady Recurring Revenue* Growth and Adjusted EBITDA Margin* Expansion  TORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) — Altus Group Limited (ʺAltus Group” or “the Company”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, announced today its financial and operating results for the third quarter ended September 30, 2025. Selected Q3 2025 InformationC$M Q3 2025 Q3 2024 % Change % Change CurrencyRevenue $133.3 $128.4 2.2%            Constant Currency*Recurring Revenue* $102.4 $95.4 5.2%          Constant CurrencyProfit (Loss) from continuing operations $0.5 $(2.9) 117.8% As ReportedAdjusted EBITDA* $25.6 $21.6 16.1%     Constant CurrencyAdjusted EBITDA margin* 19.2% 16.8% 230 bps    Constant CurrencyAnalytics Adjusted EBITDA margin* 32.8% 30.3% 250 bps    Constant CurrencyNet cash provided...

Dallas, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) — November 6, 2025…Kronos Worldwide, Inc. (NYSE:KRO) today reported a net loss of $37.0 million, or $.32 per share, in the third quarter of 2025 compared to net income of $71.8 million, or $.62 per share, in the third quarter of 2024. For the first nine months of 2025, Kronos Worldwide reported a net loss of $28.1 million, or $.24 per share, compared to net income of $99.4 million, or $.86 per share, in the first nine months of 2024. Net loss increased in the third quarter and first nine months of 2025 due to legislation enacted in Germany during the third quarter of 2025, which included a reduction of the corporate tax rate from 15% by one percentage point annually for five years, reaching 10% in 2032. As a result, we recorded a non-cash deferred income tax expense of $19.3 million...

Topline Phase 3 CATT1 data for cadisegliatin in type 1 diabetes expected second half 2026  $80 million private placement strengthens balance sheet and supports Phase 3 CATT1 completion Announced issuance of new U.S. patent covering crystalline salts and co-crystals forms of cadisegliatin with exclusivity expected out to 2041 HIGH POINT, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of type 1 diabetes (T1D), today reported financial results for the third quarter ended September 30, 2025, and provided an update on recent corporate developments. “The third quarter saw a series of meaningful achievements,” said Paul...

Gross margin decreased 400 basis points year-over-year to 39.7%Reported net loss of $4 million, adjusted EBITDA1 of $1.4 millionNet sales of $81.6 million FORT WORTH, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) — Farmer Brothers Coffee Co. (NASDAQ: FARM), a leading roaster, wholesaler and distributor of coffee, tea and allied products, announced today its first quarter fiscal 2026 financial results for the period ended Sept. 30, 2025. The company filed its Form 10-Q, which will be posted on the Investor Relations section of its website after the close of market on Thursday, Nov. 6. “Fiscal 2025 was a year of significant operational and financial improvement for Farmer Brothers. I am very pleased we were able to maintain the majority of that progress despite a very challenging economic environment during the first quarter,” said President...

Updates Full Year 2025 Financial Guidance RADNOR, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal year 2025. Third Quarter Highlights:Revenue was $104.6 million, compared to $94.8 million in the third quarter of 2024, representing growth of 10%.Software revenue was $43.8 million, compared to $35.9 million in the third quarter of 2024, representing growth of 22%. Services revenue was $60.8 million, compared to $58.9 million in the third quarter of 2024, representing growth of 3%.Net income was $1.5 million, compared to a net loss of $1.4 million in the third quarter of 2024, representing growth of 211%. Adjusted EBITDA was $35.2 million, compared to $33.1 million in the third quarter...

Quarterly revenue of $634 million and adjusted EBITDA of $58 million; GAAP income of $0.76/share and adjusted EPS of $0.39 DALLAS, Nov. 06, 2025 (GLOBE NEWSWIRE) — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2025 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts.  Q3 2025 % Change Q3 2024 YTD September 30, 2025 % Change YTD September 30, 2024Revenue $634.5 (8%) $1,982.2 (12%)Gross profit $184.4 (13%) $578.9 (17%)Net income (loss) $29.3 319% $(88.0) nmDiluted income (loss) per share $0.76 322% $(2.29) nmAdjusted diluted EPS* $0.39 (36%) $1.14 (55%)Adjusted EBITDA* $57.5 (22%) $180.0 (32%)* See “Non-GAAP Measures” below...

Third Quarter Financial Highlights:Total revenues decreased $26.2 million year over year to $422.6 million Material Handling revenues decreased $1.0 million year over year to $167.9 million, while Construction Equipment and Master Distribution revenues decreased a combined $23.9 million year over year to $256.6 million Product support revenues increased 1.1% year over year to $141.7 million for the quarter Product support gross profit percentage increased 160 basis points year over year to 47.2% Selling, general and administrative expenses decreased by $4.7 million year over year Income tax expense of $24.4 million primarily related to valuation allowance impacts of the One Big Beautiful Bill Act (“OBBBA”) Net loss available to common stockholders of $(42.3) million Basic and diluted net loss per share of $(1.31) Adjusted basic and...

TAMPA, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE:HCI), reported pre-tax income of $90.6 million and net income of $67.9 million for the third quarter of 2025 compared with pre-tax income of $14.1 million and net income of $9.4 million for the third quarter of 2024. Net income after noncontrolling interests was $65.5 million compared with $5.7 million in the third quarter of 2024. Diluted earnings per share were $4.90 in the third quarter of 2025, compared with $0.52 in the third quarter of 2024. Management Commentary“This was another strong quarter, marked by solid profitability, industry-leading net combined ratios, and meaningful growth in book value per share,” said HCI Group Chairman and Chief Executive Officer Paresh Patel. “Most importantly, we progressed our initiative to unlock shareholder value and establish...

Net sales of $1.140 billion, increased 6.0% sequentially and declined 2.0% from the year ago quarter. The midpoint of our guidance provided on August 7, 2025 was net sales of $1.130 billion. On a GAAP basis: gross profit of 55.9%; operating income of $88.9 million and 7.8% of net sales; net income attributable to common stockholders of $13.9 million; and EPS of $0.03 per diluted share. Our guidance provided on August 7, 2025 was for GAAP EPS loss per diluted share of $0.04 to $0.01. On a Non-GAAP basis: gross profit of 56.7%; operating income of $277.2 million and 24.3% of net sales; net income of $199.1 million; and EPS of $0.35 per diluted share. Our guidance provided on August 7, 2025 was for Non-GAAP EPS per diluted share of $0.30 to $0.36. Returned approximately $245.8 million to common stockholders in the September quarter through...